Beximco Pharmaceuticals (DHA:BXPHARMA) Beginning Cash Position : BDT1,096 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Beximco Pharmaceuticals Beginning Cash Position?

Beximco Pharmaceuticals's Beginning Cash Position for the quarter that ended in Mar. 2024 was BDT1,096 Mil.

Beximco Pharmaceuticals's quarterly Beginning Cash Position declined from Jun. 2023 (BDT984 Mil) to Dec. 2023 (BDT0 Mil) but then increased from Dec. 2023 (BDT0 Mil) to Mar. 2024 (BDT1,096 Mil).

Beximco Pharmaceuticals's annual Beginning Cash Position increased from Jun. 2021 (BDT635 Mil) to Jun. 2022 (BDT974 Mil) and increased from Jun. 2022 (BDT974 Mil) to Jun. 2023 (BDT1,169 Mil).

Beximco Pharmaceuticals Beginning Cash Position Historical Data

The historical data trend for Beximco Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Beginning Cash Position Chart

Beximco Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Beginning Cash Position

Get a 7-Day Free Trial

393.74

610.50

635.02

973.96

1,168.67

Beximco Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															872.65	1,246.53	983.81	-	1,095.81

Beximco Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Beximco Pharmaceuticals Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » Beginning Cash Position

Traded in Other Exchanges

BXP:UK R2WA:Germany

Address

19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205

Website

https://www.beximcopharma.com

Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Beximco Pharmaceuticals (DHA:BXPHARMA) Headlines

No Headlines